Exact Sciences Corporation (NASDAQ: EXAS) related to its sale to Abbott Laboratories. Under the terms of the proposed transaction, Exact Sciences shareholders are expected to receive $105.00 per common share.
Exact Sciences Corporation (NASDAQ: EXAS) related to its sale to Abbott Laboratories. Under the terms of the proposed transaction, Exact Sciences shareholders are expected to receive $105.00 per common share.